In contrast, two of these studies showed a trend to increased adverse events [ 17 , 18 ].
← all excerpts
The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI.
1
—
—
In contrast, two of these studies showed a trend to increased adverse events [ 17 , 18 ].